SCHEMBL30380489

SCHEMBL30380489

O=C(Cl)C=Cc1ccc2c(c1)OCCO2

nearest known ligand 0.73

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 3/20 0.73
▸ CXCL12 P48061 1/20 0.65
▸ MAPT P10636 6/20 0.64
▸ RAB9A P51151 6/20 0.64
▸ NPC1 O15118 4/20 0.64
▸ NPSR1 Q6W5P4 1/20 0.62
▸ KMT2A Q03164 2/20 0.56
▸ MAPK1 P28482 1/20 0.56
▸ HTT P42858 1/20 0.56
▸ STAT3 P40763 1/20 0.55
▸ MAOB P27338 6/20 0.55
▸ ALDH1A1 P00352 2/20 0.54
▸ MAOA P21397 1/20 0.54
▸ PKM P14618 1/20 0.53
▸ SMN1; SMN2 Q16637 1/20 0.53
▸ TRPV1 Q8NER1 1/20 0.53
▸ HPGD P15428 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24593725 1.00 KDM4E (0.73) KDM4ECXCL12MAPTRAB9ANPC1
SCHEMBL1232929 0.90 MAOB (0.66) KDM4EMAPTRAB9ANPC1MAOB
SCHEMBL1232928 0.90 MAOB (0.66) KDM4EMAPTRAB9ANPC1MAOB
SCHEMBL30579629 0.90 MAOB (0.66) KDM4EMAPTRAB9ANPC1MAOB
SCHEMBL2730201 0.85 KDM4E (1.00) KDM4ECXCL12MAPTRAB9ANPC1
SCHEMBL2730205 0.85 KDM4E (1.00) KDM4ECXCL12MAPTRAB9ANPC1
SCHEMBL10793430 0.83 KDM4E (0.73) KDM4ECXCL12MAPTRAB9ANPC1
SCHEMBL10793426 0.83 KDM4E (0.73) KDM4ECXCL12MAPTRAB9ANPC1
SCHEMBL3209529 0.83 KDM4E (0.73) KDM4ECXCL12MAPTRAB9ANPC1
SCHEMBL3209559 0.83 KDM4E (0.73) KDM4ECXCL12MAPTRAB9ANPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023055020-A1 PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING VASCULAR DISEASES, COMPRISING PIPERLONGUMINE-BASED COMPOUND AS ACTIVE INGREDIENT 주성수 2023-04-06 — — WO disclosed
Send feedback